Brainomix, an Oxford-based developer of AI imaging tools for stroke and lung fibrosis, has extended its Series C round with a new £4.8m investment. The new funding will support the expansion of the British biotech firm’s US operations, which currently consist of an extensive portfolio of FDA-cleared AI imaging solutions. As well as expanding its […] The post Brainomix extends Series C with new £5m investment appeared first on UKTN .